search
Back to results

Postoperative Balloninflation After Evacuation of cSDH (BANISH)

Primary Purpose

Chronic Subdural Hematoma

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Balloninflation
Sponsored by
Johann Wolfgang Goethe University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Subdural Hematoma focused on measuring Recurrence rate of cSDH, Outcome

Eligibility Criteria

18 Years - 99 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • age over 18 years
  • surgically treated cSDH
  • patients with an operatively implanted subdural drainage

Exclusion Criteria:

  • age under 18 years
  • Admission in critical clinical state, e.g. already to light unresponsive pupils for about 2 hours
  • conservative treatment of cSDH
  • patients without an operatively implanted subdural drainage
  • patient cannot be consented
  • participation in other clinical trials

Sites / Locations

  • University HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Sham Comparator

Arm Label

Balloninflation Group

Conservative Group

Arm Description

Patient who will perform a balloninflation after operation

Patient without performing a balloninflation

Outcomes

Primary Outcome Measures

Recurrence Rate
Reoperation of chronic subdural hematoma

Secondary Outcome Measures

Neurological Functional Outcome
Modified Rankin Scale (0-6) 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead. mRS0-3: favorable Outcome mRS: 4-6: unfavorable Outcome

Full Information

First Posted
August 6, 2019
Last Updated
December 18, 2019
Sponsor
Johann Wolfgang Goethe University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04060186
Brief Title
Postoperative Balloninflation After Evacuation of cSDH
Acronym
BANISH
Official Title
Balloninflation After Evacuation of Chronical Subdural Haematoma for Reduction of Hematoma Recurrrence: Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2019
Overall Recruitment Status
Unknown status
Study Start Date
January 1, 2020 (Anticipated)
Primary Completion Date
August 30, 2021 (Anticipated)
Study Completion Date
February 28, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Johann Wolfgang Goethe University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this prospective, randomized, multicenter trial shall patients with chronic subdural hematoma (cSDH) recruited, who were surgically treated. Initially, we would divide the patients randomized into two groups: Patients with supervised blow-maneuver and without. After surgical treatment of cSDH with insertion of a subdural drain, one group would perform a supervised blow maneuver ("Valsalva maneuver") every hour for five minutes from 10:00 to 20:00. In the other group, the standard care would be performed. The subdural drain would be explanted 2days after operation and a postoperative CT scan would routinely be performed. After hospital discharge, the patient would be rechecked in an ambulant setting and would receive CT scan as clinical standard. Recurrence of hematoma is defined as recurrent hematoma which should be reoperated. After 3 and 6 months we would evaluate the outcome of patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Subdural Hematoma
Keywords
Recurrence rate of cSDH, Outcome

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Balloninflation Group
Arm Type
Active Comparator
Arm Description
Patient who will perform a balloninflation after operation
Arm Title
Conservative Group
Arm Type
Sham Comparator
Arm Description
Patient without performing a balloninflation
Intervention Type
Procedure
Intervention Name(s)
Balloninflation
Intervention Description
Patient will inflate into a ballon made by a handglove 2-3times/h from 8:00-20:00 after evacuation of chronic subdural hematoma.
Primary Outcome Measure Information:
Title
Recurrence Rate
Description
Reoperation of chronic subdural hematoma
Time Frame
3 Months
Secondary Outcome Measure Information:
Title
Neurological Functional Outcome
Description
Modified Rankin Scale (0-6) 0 - No symptoms. - No significant disability. Able to carry out all usual activities, despite some symptoms. - Slight disability. Able to look after own affairs without assistance, but unable to carry out all previous activities. - Moderate disability. Requires some help, but able to walk unassisted. - Moderately severe disability. Unable to attend to own bodily needs without assistance, and unable to walk unassisted. - Severe disability. Requires constant nursing care and attention, bedridden, incontinent. - Dead. mRS0-3: favorable Outcome mRS: 4-6: unfavorable Outcome
Time Frame
6 Months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age over 18 years surgically treated cSDH patients with an operatively implanted subdural drainage Exclusion Criteria: age under 18 years Admission in critical clinical state, e.g. already to light unresponsive pupils for about 2 hours conservative treatment of cSDH patients without an operatively implanted subdural drainage patient cannot be consented participation in other clinical trials
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sae-Yeon Won, MD
Phone
06963014291
Email
sae-yeon.won@kgu.de
First Name & Middle Initial & Last Name or Official Title & Degree
Anne Sicking
Phone
06963014291
Email
anne.sicking@kgu.de
Facility Information:
Facility Name
University Hospital
City
Frankfurt Niederrad
State/Province
Hessen
ZIP/Postal Code
60528
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sae-Yeon Won, MD
Phone
06963015295
Email
sae-yeon.won@kgu.de

12. IPD Sharing Statement

Learn more about this trial

Postoperative Balloninflation After Evacuation of cSDH

We'll reach out to this number within 24 hrs